" /> Onyvax-P - CISMeF





Preferred Label : Onyvax-P;

MeSH note : an allogeneic whole-cell vaccine, for the potential treatment of prostate cancer; in phase II clinical trials (Oct 2005);

Is substance : O;

Details


You can consult :


Nous contacter.
12/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.